Back
Adagene 10K Form
Sell
30
ADAG
Adagene
Last Price:
3.05
Seasonality Move:
83.94%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ADAG News And Ratings
See the #1 stock for the next 7 days that we like better than ADAG
ADAG Financial Statistics
Sales & Book Value
| Annual Sales: | $18.11M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.28 |
| Price / Book: | 2.43 |
Profitability
| EPS (TTM): | -0.72500 |
|---|---|
| Net Income (TTM): | $-31.85M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Adagene Earnings Forecast
Key Adagene Financial Ratios
- The Research & Development expenses have been 202.30% of Revenue.
- The Interest Expense is -5.85% of Operating Income.
- The Net Earning history of ADAG is -104.61% of Total Revenues.
- Per Share Earnings over the last 6 years have been positive in 1 years.
Adagene Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ADAG |
| Website: | adagene.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |